Provident Trust Company’s GSK GSK Stock Holding History

Provident Trust Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,953,602	Closed	-$162M	–	27
2024 Q3	$162M	Buy	3,953,602 +66,765	+2%	+$2.73M	2.91%	15
2024 Q2	$150M	Buy	3,886,837 +67,297	+2%	+$2.83M	2.78%	16
2024 Q1	$164M	Buy	3,819,540 +102,710	+3%	+$4.24M	3.04%	15
2023 Q4	$138M	Buy	3,716,830 +1,297,385	+54%	+$46.6M	2.82%	16
2023 Q3	$87.7M	Buy	2,419,445 +617,705	+34%	+$21.9M	2.03%	15
2023 Q2	$64.2M	Buy	+1,801,740	New	+$64.6M	1.47%	16

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Provident Trust Company's GSK Position: Q4 2024 in Review

Provident Trust Company sold out of GSK (GSK) in Q4 2024, closing a stake of 3,953,602 shares — an estimated $162M sold.

Provident Trust Company first reported a position in GSK in Q2 2023 and held it in 6 quarters. The position peaked at $164M in Q1 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Provident Trust Company reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Provident Trust Company sold 3,953,602 GSK shares in Q4 2024, an estimated $162M.
Provident Trust Company first reported a position in GSK in Q2 2023 and held it in 6 quarters.
Provident Trust Company's GSK position peaked at $164M in Q1 2024.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Provident Trust Company's 13F filing for Q4 2024, filed 31 Jan 2025.